Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Sorbitol on Lamivudine Exposure
NCT02634073Phase 4Completed
- Sponsor
- ViiV Healthcare
- Start
- Jan 2016
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lamivudine in human immunodeficiency virus type 1 infection (HIV-1), sponsored by ViiV Healthcare. Started Jan 2016; status: completed.
02
Drugs
lamivudine
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT02634073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02634073.